Market closedNon-fractionalADR
Smith & Nephew/SNN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Smith & Nephew
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Ticker
SNN
Sector
Healthcare
Trading on
NYSE
Industry
Medical Equipment & Supplies
Headquarters
Watford, United Kingdom
Employees
18,452
Website
www.smith-nephew.com
Smith & Nephew Metrics
BasicAdvanced
$11B
Market cap
42.04
P/E ratio
$0.60
EPS
0.81
Beta
$0.30
Dividend rate
2.96%
Dividend yield
Price and volume
Market cap
$11B
Beta
0.81
52-week high
$32.29
52-week low
$21.53
Average daily volume
20
Dividend rate
$0.30
Financial strength
Current ratio
1.775
Quick ratio
0.72
Long term debt to equity
44.451
Total debt to equity
59.114
Dividend payout ratio (TTM)
124.33%
Enterprise value to free cash flow
71.945
Interest coverage (TTM)
4.84%
Management effectiveness
Return on assets (TTM)
2.64%
Return on equity (TTM)
5.02%
Return on investment (TTM)
3.29%
Valuation
Price to earnings (TTM)
42.041
Price to revenue (TTM)
1.988
Price to book
2.117
Price to tangible book (TTM)
9.894
Dividend yield (TTM)
1.19%
Forward dividend yield
2.96%
Growth
Revenue change (TTM)
6.40%
Earnings per share change (TTM)
18.27%
3-year revenue growth (CAGR)
6.76%
3-year earnings per share growth (CAGR)
-16.14%
What the Analysts think about Smith & Nephew
Analyst Ratings
Majority rating from 4 analysts.
Smith & Nephew Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$2.8B
2.96%
Net income
$91M
-47.09%
Profit margin
3.23%
-48.65%
Smith & Nephew Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 22
Q4 22
Q2 23
Q4 23
Q2 24
Actual
$0.76
$0.88
$0.70
$0.96
-
Expected
$0.80
$0.80
$0.58
$0.74
$0.58
Surprise
-5.00%
10.00%
20.34%
29.46%
-
Smith & Nephew News
AllArticlesVideos
Activist Cevian has a stake in medical device company Smith & Nephew. How it may help improve margins
CNBC·2 weeks ago
Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge
Benzinga·3 weeks ago
Smith & Nephew shares surge as activist Cevian Capital reveals 5% stake
Market Watch·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractionalADR
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Smith & Nephew stock?
Smith & Nephew (SNN) has a market cap of $11B as of July 27, 2024.
What is the P/E ratio for Smith & Nephew stock?
The price to earnings (P/E) ratio for Smith & Nephew (SNN) stock is 42.04 as of July 27, 2024.
Does Smith & Nephew stock pay dividends?
Yes, the Smith & Nephew (SNN) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $0.3021 and the yield is 2.96%. Smith & Nephew has a payout ratio of 124.33% on a trailing twelve-month basis.
When is the next Smith & Nephew dividend payment date?
The next Smith & Nephew (SNN) dividend payment date is unconfirmed.
What is the beta indicator for Smith & Nephew?
Smith & Nephew (SNN) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Smith & Nephew stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.